NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Posts Earnings Results

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) issued its earnings results on Tuesday. The company reported C($0.16) EPS for the quarter, reports. NorthWest Health Prop Real Est Inv Trust had a negative net margin of 75.29% and a negative return on equity of 14.67%. The firm had revenue of C$102.27 million during the quarter.

NorthWest Health Prop Real Est Inv Trust Trading Up 2.0%

TSE:NWH.UN traded up C$0.12 during mid-day trading on Thursday, hitting C$5.98. 151,092 shares of the company’s stock were exchanged, compared to its average volume of 690,888. The company has a 50 day simple moving average of C$5.55 and a 200-day simple moving average of C$5.26. The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42. NorthWest Health Prop Real Est Inv Trust has a fifty-two week low of C$4.44 and a fifty-two week high of C$6.07. The firm has a market capitalization of C$1.49 billion, a P/E ratio of 29.58, a PEG ratio of 0.74 and a beta of 1.78.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on NWH.UN shares. BMO Capital Markets raised their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a report on Thursday, November 13th. Canadian Imperial Bank of Commerce lifted their price objective on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a research report on Thursday, November 13th. Royal Bank Of Canada set a C$5.50 price objective on NorthWest Health Prop Real Est Inv Trust and gave the stock a “sector perform” rating in a research note on Monday, November 24th. Finally, Scotiabank increased their target price on NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a report on Thursday, November 13th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, NorthWest Health Prop Real Est Inv Trust currently has an average rating of “Moderate Buy” and a consensus price target of C$6.00.

About NorthWest Health Prop Real Est Inv Trust

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.